You are here

  • Home
  • Archive
  • Volume 69, Issue 3
  • Relationship between the clinical response to adalimumab treatment and serum levels of adalimumab and anti-adalimumab antibodies in patients with psoriatic arthritis

Article Text

Article menu
Download PDFPDF
Letter
Relationship between the clinical response to adalimumab treatment and serum levels of adalimumab and anti-adalimumab antibodies in patients with psoriatic arthritis

https://doi.org/10.1136/ard.2009.108787

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests BACD is a member of the advisory board of Abbott and has received honoraria for lectures. PPT has served as a consultant to Abbott, Schering-Plough, UCB and Wyeth.

    • Ethics approval Ethics committee approval from Academic Medical Centre/University of Amsterdam.

    • Patient consent Patient consent received.

    • Provenance and peer review Not commissioned; externally peer reviewed.